No Evidence for Evolution of Protease Inhibitor Resistance from Standard Genotyping, After Three Years of Treatment with Darunavir/Ritonavir, With or Without Nucleoside Analogues

被引：10

作者：

Pulido, Federico ^{[1
]}

Arribas, Jose ^{[2
]}

Hill, Andrew ^{[3
]}

Moecklinghoff, Christiane ^{[4
]}

机构：

[1] Hosp 12 Octubre, HIV Unit, E-28041 Madrid, Spain

[2] Hosp IdiPaz, Madrid, Spain

[3] Univ Liverpool, Pharmacol Res Labs, Liverpool L69 3BX, Merseyside, England

[4] Janssen, Neuss, Germany

来源：

AIDS RESEARCH AND HUMAN RETROVIRUSES | 2012年 / 28卷 / 10期

关键词：

HIV-1; DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; LOPINAVIR/RITONAVIR MONOTHERAPY; MAINTENANCE THERAPY; MONET TRIAL; RNA; INFECTION; MUTATIONS; EMERGENCE; COPIES/ML;

D O I：

10.1089/aid.2011.0256

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1167 / 1169

页数：3

共 15 条

[1]

[Anonymous], STANF U HIV DRUG RES

[2] The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml [J].

Arribas, Jose R. ;

Horban, Andrzej ;

Gerstoft, Jan ;

Faetkenheuer, Gerdt ;

Nelson, Mark ;

Clumeck, Nathan ;

Pulido, Federico ;

Hill, Andrew ;

van Delft, Yvon ;

Stark, Thomas ;

Moecklinghoff, Christiane .

AIDS, 2010, 24 (02) :223-230

[3] Antiretroviral monotherapy: should we abandon the principles of successful antiretroviral therapy? [J].

Battegay, Manuel ;

Bucher, Heiner C. .

AIDS, 2010, 24 (07) :1057-1059

[4] HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review [J].

Bierman, Wouter F. W. ;

van Agtmael, Michiel A. ;

Nijhuis, Monique ;

Danner, Sven A. ;

Boucher, Charles A. B. .

AIDS, 2009, 23 (03) :279-291

[5]

Blackham J, 2005, AIDS, V19, P487, DOI 10.1097/01.aids.0000162337.58557.3d

[6] 96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA <50 copies/mL at baseline [J].

Clumeck, Nathan ;

Rieger, Armin ;

Denes Banhegyi ;

Schmidt, Wolfgang ;

Hill, Andrew ;

Van Delft, Yvonne ;

Moecklinghoff, Christiane ;

Arribas, Jose .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (08) :1878-1885

[7] Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: A systematic review of clinical trials [J].

Gupta, Ravindra ;

Hill, Andrew ;

Sawyer, Anthony W. ;

Pillay, Deenan .

CLINICAL INFECTIOUS DISEASES, 2008, 47 (05) :712-722

[8] Antiretroviral drug resistance testing in adult HIV-1 infection:: 2008 recommendations of an International AIDS Society-USA panel [J].

Hirsch, Martin S. ;

Guenthard, Huldrych F. ;

Schapiro, Jonathan M. ;

Brun-Vezinet, Francoise ;

Clotet, Bonaventura ;

Hammer, Scott M. ;

Johnson, Victoria A. ;

Kuritzkes, Daniel R. ;

Mellors, John W. ;

Pillay, Deenan ;

Yeni, Patrick G. ;

Jacobsen, Donna M. ;

Richman, Douglas D. .

CLINICAL INFECTIOUS DISEASES, 2008, 47 (02) :266-285

[9] Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy [J].

McKinnon, John E. ;

Delgado, Rafael ;

Pulido, Federico ;

Shao, Wei ;

Arribas, Jose R. ;

Mellors, John W. .

ANTIVIRAL THERAPY, 2011, 16 (05) :725-732

[10] Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial [J].

Meynard, Jean-Luc ;

Bouteloup, Vincent ;

Landman, Roland ;

Bonnard, Philippe ;

Baillat, Vincent ;

Cabie, Andre ;

Kolta, Sami ;

Izopet, Jacques ;

Taburet, Anne-Marie ;

Mercie, Patrick ;

Chene, Genevieve ;

Girard, Pierre-Marie .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (11) :2436-2444

← 1 2 →